1.Ito Y., Kajihara M., Imanishi Y. Materials for enhancing cell adhesion by immobilization of cell-adhesive peptide. J Biomed Mater Res. 1991. 25:1325–37.
Article
2.van Driel M., Koedam M., Buurman CJ., Roelse M., Weyts F., Chiba H., Uitter linden AG., Pols HA., van Leeuwen JP. Evidence that both 1α,25-Dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization. J Cell Biochem. 2006. 99:922–35.
Article
3.Miyahara T., Simoura T., Osahune N., Uchida Y., Sakuma T., Nemoto N., Kozakai A., Takamura T., Yamazaki R., Higuchi S., Chiba H., Iba K., Sawada N. A highly potent 26,27-Hexafluoro-1α,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells. Calcif Tissue Int. 2002. 70:488–95.
4.Puleo DA., Nanci A. Understanding and controlling the bone-implant interface. Biomaterials. 1999. 20:2311–21.
Article
5.Agrawal CM., Niederauer GG., Athanasiou KA. Fabrication and characterization of PLA-PGA orthopaedic implants. Tissue Eng. 1995. 1:241–52.
6.Kulkarni RK., Moore G., Hegyeli AF., Leonard F. Biodegradable poly(lactic acid) polymers. J Biomed Mater Res. 1971. 5:169–81.
Article
7.Panyam J., Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003. 55:329–47.
Article
8.Li LH., Kong YM., Kim HW., Kim YW., Kim HE., Heo SJ., Koak JY. Improved biological performance of Ti implants due to surface modification by micro-arc oxidation. Biomaterials. 2004. 25:2867–75.
Article
9.Choi JW., Heo SJ., Koak JY., Kim SK., Lim YJ., Kim SH., Lee JB. Biological responses of anodized titanium implants under different current voltages. J Oral Rehabil. 2006. 33:889–97.
Article
10.Woosley J., Turnbull R., Kim K. Field injection electrostatic spraying of liquid hydrogen. J Appl Phys. 1988. 64:4278–85.
Article
11.Kim K., Turnbull RJ. Generation of charged drops of insulating liquids by electrostatic spraying. J Appl Phys. 1976. 47:1964–9.
Article
12.Cory AH., Owen TC., Barltrop JA., Cory JG. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 1991. 3:207–12.
Article
13.van Leeuwen JP., van Driel M., van den Bemd GJ., Pols HA. Vitamin D control of osteoblast function and bone extracellular matrix mineralization. Crit Rev Eukaryot Gene Expr. 2001. 11:199–226.
14.Siggelkow H., Schulz H., Kaesler S., Benzler K., Atkinson MJ., Hufner M. 1,25 dihydroxyvitamin-D3 attenuates the confluence-dependent differences in the osteoblast characteristic proteins alkaline phosphatase, procollagen I peptide, and osteocalcin. Calcif Tissue Int. 1999. 64:414–21.
Article
15.Raz P., Lohmann CH., Turner J., Wang L., Poythress N., Blanchard C., Boyan BD., Schwartz Z. 1α,25-(OH)2D3 Regulation of integrin expression is substrate dependent. J Biomed Mater Res A. 2004. 71:217–25.
Article
16.Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) devices. Biomaterials. 2000. 21:2475–90.
17.Shive MS., Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997. 28:5–24.
18.Owen TA., Aronow M., Shalhoub V., Barone LM., Wilming L., TAssinari MS., Kennedy MB., Pockwines S., Lian JB., Stein GS. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationship in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol. 1990. 143:420–30.
19.Anselme K. Osteoblast adhesion on biomaterials. Biomaterials. 2000. 21:667–81.
Article
20.Li LH., Kim HW., Lee SH., Kong YM., Kim HE. Biocompatibility of titanium implants modified by mi-croarc oxidation and hydroxyapatite coating. J Biomed Mater Res A. 2005. 73:48–54.
Article
21.Boyan BD., Batzer R., Kieswetter K., Liu Y., Cochran DL., Szmuckler-Moncler S., Dean DD., Schwartz Z. Titanium surface roughness alters responsiveness of MG63 os-teoblastlike cells to 1α,25-(OH)2D3. J Biomed Mater Res. 1998. 39:77–85.
Article
22.Zhao G., Schwartz Z., Wieland M., Rupp F., Geis-Gerstorfer J., Cochran DL., Boyan BD. High surface energy enhances cell response to titanium substrate microstructure. J Biomed Mater Res A. 2005. 74:49–58.
Article
23.Lohmann CH., Bonewald LF., Sisk MA., Sylvia VL., Cochran DL., Dean DD., Boyan BD., Schwartz Z. Maturation State Determines the Response of Osteogenic Cells to Surface Roughness and 1,25-Dihydroxyvitamin D3 J Bone Miner Res. 2000. 15:1169–80.
24.Lohmann CH., Sagun R Jr. Sylvia VL, Cochran DL, Dean DD, Boyan BD, Schwartz Z. Surface roughness modulates the response of MG63 osteoblast-like cells to 1,25-(OH) 2D3 through regulation of phospholipase A2 activity and activation of proteinkinase A. J Biomed Mater Res. 1999. 47:139–51.
25.Franceschi RT., James WM., Zerlauth G. 1α,25-dihydroxy vitamin D3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line. J Cell Physiol. 1985. 123:401–9.